BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2007
View Archived Issues
Micromet publishes two studies on its BiTE antibodies
Read More
Preclinical data on AV-101 indicate its potential for the treatment of PD
Read More
Targacept reports negative results from phase II clinical trial of TC-2696
Read More
Alpharma reports positive results from phase III trial of ALO-01 for pain relief
Read More
LifeCycle Pharma initiates phase II clinical trial of immunosuppressant LCP-Tacro
Read More
Novel therapeutic agents for neurological disorders reported in recent patents
Read More
Novel therapeutic agents for allergic and respiratory disorders disclosed in recent patents
Read More
4SC reports positive initial results from phase IIa clinical study of SC-12267 for RA
Read More
Recent Vitae patent discloses novel antihypertensive agents
Read More
OncoVista licenses OSI-7904L from OSI Pharmaceuticals
Read More
Arana Therapeutics provides an update on the clinical development plans for ART-621
Read More
Elan presents third quarter 2007 results
Read More
In vivo antimetastatic activity of novel irreversible uPA inhibitors
Read More
Mirodenafil significantly improves erectile dysfunction in double-blind study
Read More
Treatment effects and cardiovascular safety of dapoxetine assessed in phase III study
Read More
Rasagiline may slow deterioration of amyotrophic lateral sclerosis
Read More
Nippon Kayaku initiates phase II study of NK-105
Read More
Seikagaku initiates phase II study of SI-6603 for lumbar disc herniation
Read More
BioMarin enters research and option agreement with IGAN for IgA proteases
Read More
Eisai and BioArctic sign licensing agreement for BAN-2401 for Alzheimer's disease
Read More
NeuroSearch initiates phase I clinical study of NSD-644 for the treatment of pain
Read More
Bayer Schering Pharma takes next step towards important oral contraceptive milestone
Read More
Betaferon is only drug to delay disability in patients treated after first MS attack
Read More
Intercell's MAA for Japanese encephalitis vaccine is submitted to EMEA
Read More
E.U. approves Vectibix for the treatment of metastatic colorectal cancer
Read More